News Summary

Israel is set to perform the world’s first human spinal cord implant using a patient’s own cells, a groundbreaking development in regenerative medicine that could allow paralyzed individuals to stand and walk again. The procedure, to be conducted in the coming months in Israel, is being led by Professor Tal Dvir of Tel Aviv University and the Israeli biotech company Matricelf. This innovative therapy involves engineering a personalized three-dimensional human spinal cord using the patient’s blood cells and fat tissue to create a custom hydrogel scaffold. The lab-grown spinal cord is designed to fuse with healthy tissue, replacing scarred areas and reconnecting the nervous system. Preliminary animal studies have shown promising results, with rats regaining the ability to walk. The Israeli Ministry of Health has granted preliminary approval for “compassionate use” trials in eight patients. If successful, this treatment could become a new standard of care in spinal cord repair, addressing a significant unmet need in the medical field.